Ann M. Leen

Companies

• Kalaris Therapeutics, Inc.Chief Scientific Officer Jul 30, 2020 to Feb 3, 2023¹
• Marker Therapeutics, Inc.Chief Scientific Officer Dec 28, 2018 to Feb 24, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKalaris Therapeutics, Inc. KLRS2,412,160 shares³$4.6M at $1.91Feb 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 2, 2023Granted 43,750 shares of Kalaris Therapeutics, Inc.³
• Aug 16, 2022Granted 15,000 shares of Kalaris Therapeutics, Inc.⁴
• Jul 1, 2022Granted 14,000 shares of Kalaris Therapeutics, Inc.³
• Jan 18, 2022Granted 23,256 shares of Kalaris Therapeutics, Inc.³
• Nov 16, 2021Sold 100 shares at $21.76 of Kalaris Therapeutics, Inc.⁵
• Nov 15, 2021Sold 6,122 shares at $21.92 of Kalaris Therapeutics, Inc.⁵
• Nov 12, 2021Sold 500 shares at $23.18 of Kalaris Therapeutics, Inc.⁵
• Nov 12, 2021Sold 14,266 shares at $22.26 of Kalaris Therapeutics, Inc.⁵